Different solvent extracts of Pleurotus giganteus fruiting bodies were tested for antifungal activities against Candida species responsible for human infections. The lipids extracted from the ethyl acetate fraction significantly inhibited the growth of all the Candida species tested. Analysis by GC/MS revealed lipid components such as fatty acids, fatty acid methyl esters, ergosterol, and ergosterol derivatives. The sample with high amounts of fatty acid methyl esters was the most effective antifungal agent. The samples were not cytotoxic to a mammalian cell line, mouse embryonic fibroblasts BALB/c 3T3 clone A31. To our knowledge, this is the first report of antifungal activity of the lipid components of Pleurotus giganteus against Candida species.
Fungal infections are problematic for human health and are responsible for high rates of morbidity and mortality worldwide. Species of Candida are the dominant cause of opportunistic mycoses and among them, C. albicans, C. glabrata, C. parapsilosis, C. tropicalis and C. krusei account for 95-97% of all Candida infections [1, 2] . C. albicans and C. tropicalis are susceptible to polyenes, flucytosine, azoles and echinocandins, while C. glabrata is either susceptible or resistant to fluconazole [3] . Furthermore, C. krusei displays decreased susceptibility to amphotericin B, as well as fluconazole. Considering the increasing incidence of drugresistant Candida infections, the search for more effective anti-Candida agents as an alternative to synthetic ones is needed. The interest in natural products from medicinal plants as a source of anti-Candida agents has grown dramatically. A wide variety of plant extracts have been reported to have anti-C. albicans activity. Examples include propolis, Punica granatum (pomegranate), Streblus asper (Siamese rough bush), Vitis vinifera (common grape vine), and tea tree oil from Melaleuca alternifolia [4] .
Medicinal mushrooms are relatively less researched for their antifungal properties. However, in the last five years, there has been a renewed interest in using mushrooms as antimicrobial agents. Lentinula edodes (shiitake), Boletus edulis (Penny bun), Pleurotus ostreatus (oyster mushroom), Coprinus comatus (shaggy mane), Astraeus hygrometricus (earthstar mushroom), and Cordyceps militaris were shown to exhibit antifungal activity against C. albicans [5] [6] [7] [8] . Pleurotus giganteus (Zhudugu, Dabeijun, morning glory mushroom), a saprobic mushroom, is one of the largest mushroom which grows on soil either as solitary or gregarious fruiting bodies [9] . This mushroom has gained popularity in China for its culinary properties. The medicinal properties of this mushroom are less known. We have previously reported the hepatoprotective and neuronal stimulating effects of P. giganteus [10, 11] . In this study the antifungal activities of different solvent extracts of this mushroom were evaluated. The extracts prepared with different solvents had different profiles of fatty acids, and fatty Strains were grown with different mushroom extracts at the concentrations shown for two days on YEPD media. Growth was scored from "-" to "++++", indicating no growth to strong growth.
acids have been shown to demonstrate antimicrobial activities [12] .The main metabolites / components in the extracts were analysed by GC-MS. As a preliminary in vitro toxicity assessment, the P. giganteus extracts were also investigated for cytotoxicity to mouse embryonic 3T3 fibroblast cells.
The anti-Candida activity of methanol, ethyl acetate and aqueous extracts of P. giganteus against all yeast species tested are summarised in Table 1 . Candida species showed strong growth (denoted as "++++") when extracts were not added to the medium. The aqueous extract had minimum or no inhibitory activity against all Candida spp. The ethyl acetate extract completely inhibited the growth of all Candida spp. when tested at 50 and 100 µg/mL. Thus, the ethyl acetate extract was fractionated to identify the active component/s responsible for the antifungal activity. Sub-fractions A to H were obtained and the minimum inhibitory concentration (MIC) values against all the tested yeasts are given in Table 2 .
The MIC values for all the Candida spp. tested, ranged from 2.0 ± 1.0 to 10.3 ± 2.5 µg/mL for sub-fraction A; and 9. The methanol, ethyl acetate, and aqueous extracts were not toxic to 3T3 fibroblasts cells and the IC 50 values were more than 2 mg/mL ( Fig. 1 ). Meanwhile, cell viability (%) decreased steadily with increasing concentrations of sub-fractions A and B at levels up to 500 µg/mL. The IC 50 value of sub-fraction A was 352 µg/mL and the R 2 value was 0.9609. For sub-fraction B, the IC 50 was 362 µg/mL with the R 2 value recorded at 0.9552.
To our knowledge, this is the first report on the antifungal activity of the lipid components of P. giganteus. It has been reported that crude extracts of P. ostreatus and C. comatus inhibited the growth of C. albicans [6] . However, the MICs were much higher (up to 1 mg/mL) when compared with this study, which recorded an MIC of 100 µg/mL. The sub-fractions A and B were shown to contain several bioactive components. Since they are blends of fatty acids and fatty acid methyl esters, they do not act on specific targets in the fungal cells, and fungal resistance may be unlikely to occur. Furthermore, fatty acids and their methyl esters were reported to have fungicidal activity to C. albicans, C. krusei, C. tropicalis and C. parapsilosis [13] . The entities might play crucial roles in lipophilic or hydrophilic effects on the cell wall and membrane, hence affecting the distribution of the lipids in the cells [14] . Moreover, ergosterol present in the sample could disrupt the ergosterol biosynthesis pathway in the yeast, causing growth inhibition or cell death. This was further supported by a study of Irshad et al. [15] , who reported that ergosterol-rich Cassia fistula oil significantly decreased the in vivo ergosterol content in the Candida cell wall.
In this study, the sub-fractions A and B were not cytotoxic to mouse fibroblasts at the concentrations tested ( Fig. 1) . Animal testing is becoming less popular and is gradually being replaced by in vitro methods for toxicity assessment of pharmaceutical products. In conclusion, P. giganteus lipids are promising natural products to be further explored as antifungal agents against Candida species. 
Extracts preparation:
The fresh fruiting bodies of P. giganteus were sliced, freeze-dried and ground to a fine powder (500 g). The mushroom powder was extracted with 80% MeOH to yield a MeOH extract (115 g, 23.0%). This (125 g) was further partitioned in EtOAc-H 2 O (100 mL: 100 mL) to give an EtOAc-soluble extract (6.96 g, 6.05%) and a H 2 O extract (74.2 g, 64.52%).
Fractionation of extract:
The EtOAc extract (5.00 g) was further fractionated by CC over silica gel. The extract was eluted with nhexane containing increasing concentrations of acetone to obtain 8 fractions (A to H) based on similarity of spots on TLC. [16] . The absorbance was measured at 550 nm using a microplate reader. The IC 50 is the concentration of extract or fraction that reduced fibroblast cell growth by 50%.
Anti-yeast activity: Candida albicans WM1172, C. albicans ATCC90028, C. dubliniensis, C. glabrata CBS138, C. glabrata ATCC90030, C. krusei ATCC6258, C. pseudotropicalis, and C. tropicalis WM30 were used in this study. The yeast inhibition assay was performed according to the method of Macreadie et al. [17] . The yeast strains were grown in YEPD (1% yeast extract, 2% peptone, 2% glucose). If required, media were solidified by the addition of 1.5% agar. Yeast inocula (100 µL) with a starting optical density at A 595 of 0.02-0.04 were added to each well of a 96well microplate (Orange Scientific, Braine-l'Alleud, Belgium). Mushroom extracts were then added as two-fold serial dilutions commencing with a 100 µg/mL concentration. Fluconazole (0.1 mM) and amphotericin B (1.0 mM) were used as positive controls. A growth control DMSO solvent alone was also included. The microplate was incubated in a microplate shaker at 35ºC. After 2 h and 4 h incubation, the A 595 was recorded using a microplate reader (Sunrise™, Tecan, Austria). Each sample was assayed in triplicate. The lowest concentration of extracts that inhibited growth of Candida spp. is the minimum inhibitory concentration (MIC).
Gas chromatography-mass spectrometry (GCMS):
GCMS analysis was performed on sub-fractions A and B using Network Gas Chromatography system (Agilent Technologies 6890N) equipped with an Inert Mass Selective Detector (Agilent Technologies 5975) (70eV direct inlet) on a HP-5ms (5% phenyl methyl siloxane) capillary column (30 m × 250 µm × 0.25 µm) initially set at 150ºC, then increased at 5ºC per min to 300ºC and held for 10 min. Helium was used as carrier gas at a flow rate of 1 mL per min. The total ion chromatogram obtained was autointegrated by chemstation and the constituents were identified by comparison with the accompanying mass-spectra database (Wiley 9 th edition with NIST 11 Mass Spectral Library, USA) wherever possible.
